Tracy L. McGregor
Alnylam Pharmaceuticals (United States)(US)Vanderbilt University(US)
Publications by Year
Research Areas
Kidney Stones and Urolithiasis Treatments, Porphyrin Metabolism and Disorders, Biomedical Research and Pathophysiology, Metabolism and Genetic Disorders, Pediatric Urology and Nephrology Studies
Most-Cited Works
- → Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1(2021)476 cited
- → Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between(2014)375 cited
- → Phenotype risk scores identify patients with unrecognized Mendelian disease patterns(2018)238 cited
- → Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study(2015)139 cited
- → Acute Kidney Injury Incidence in Noncritically Ill Hospitalized Children, Adolescents, and Young Adults: A Retrospective Observational Study(2015)139 cited
- → An Evolutionary Genomic Approach to Identify Genes Involved in Human Birth Timing(2011)112 cited